On Demand Oncology CME Course Library.

Free Oncology CME Online Education Activities From Horizon CME (APPOS)*

Featured Activities (BiSpecifics)

Bispecific Antibodies: Past, Present, and Future (Through Sep 22, 2026)

This multi-faculty CME course is the first installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

Mitigation and Management of Bispecific Antibody Toxicities in Myeloma & Lymphoma (Through Sep 22, 2026)

This multi-faculty CME course is the second installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

Effective Implementation of Bispecific Antibodies (Through Sep 22, 2026)

This multi-faculty CME course is the final installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

CATEGORY: SOLID TUMOR

Targeting Soft-Tissue Tumors: Advances in the Management of Desmoid Tumors and TGCT (Through June 30, 2026) - Course Access on Mycme.com

Current Approaches to Systemic Management of Regionally Advanced or Metastatic Melanoma (Through Sept 5, 2026) -

Molecular Imaging for Metastatic Breast Cancer (Through Dec 1, 2026) -

Evolving Treatment Landscape in HR+/HER2- Metastatic Breast Cancer: Integrating Biomarkers and Novel Targeted Agents (Through Dec 1, 2026)

Practical Approaches to Identifying and Managing Adverse Events in HR+/HER2- Metastatic Breast Cancer (Through Dec 1, 2026)

Supportive Care in Individuals with Head & Neck Cancer (Through Jan 23, 2027)

Living With Small Cell Lung Cancer (SCLC): Current Therapies and Looking Towards the Future (Through Jan 23, 2027)

Spotlight on Desmoid Tumors: Bridging Knowledge Gaps for Optimal Patient Care (Through Feb 13, 2027)

CATEGORY: HEMATOLOGY

Moving Forward in Multiple Myeloma (Through Sept 5, 2026)

Breaking the Cycle: Evolving Strategies for Pain Management in Sickle Disease (Through Sept 5, 2026)

Mitigation and Management of Bispecific Antibody Toxicities in Myeloma & Lymphoma (Through Sept 22, 2026)

Managing CAR T-cell Related Toxicities: The Acute, The Subacute, and The Chronic (Through Jan 23, 2027)

Closing the Gap: Optimizing AML Treatment in Aging Adults (Through Jan 23, 2027)

CATEGORY: GENERAL CANCER

Identifying and Managing Common Immunotherapy-Related Adverse Events (Through September 5, 2026)

Incorporating Occupational Therapy into Cancer Care: Enhancing Independence and Quality of Life (Through September 5, 2026)

Optimizing Skeletal Health During Cancer Treatment: Diagnosing Osteoporosis and Preventing Fractures (Through September 5, 2026)

Management of Cancer-Associated Thrombosis (CAT) (Through Sept 5, 2026)

Advancing Cancer Therapies: The Role of Phase I Clinical Trials (Through Sept 5, 2026)

Navigating the Complexities of Cellular Therapy: Identifying Risks and Interventions to Minimize Toxicity (Through Sept 5, 2026)

Bispecific Antibodies: Past, Present, and Future (Through Sept 22, 2026)

Effective Implementation of Bispecific Antibodies (Through Sept 22, 2026)

Fe-sponse Ready: Managing IV Iron Infusions with Confidence (Through Jan 23, 2027)

Radiation Oncology: Demystifying The Magic (Through Jan 23, 2027)

Integrative Oncology: A Patient Centered and Multidisciplinary Approach to Cancer Care (A Panel Discussion) (Through Jan 23, 2027)

Fertility Preservation in Cancer Patients (Through Jan 23, 2027)

Beyond the Infusion Chair: Practical Implications of Subcutaneous Immunotherapies (Through Jan 23, 2027)

Navigating Herbal and Supplement Use in Cancer Patients (Through Jan 23, 2027)

Why Oncology On-Demand?

Grow your cancer care knowledge and improve patient care

100% free of charge

The majority of our online on-demand CME courses are offered free! Which means you'll still have money for lunch.

Expert Faculty Speakers

All of our faculty presenters are experts in their respective fields and disciplines.

Anytime, Anywhere

On-demand means that you can take our CME courses anywhere at anytime. Even in your pajamas!